| Ascendis Pharma Switzerland GmbH - Yorvipath 294 μg/0.98 ml, Injektionslösung im Fertigpen |
| 69889 | | 02 | | Yorvipath 294 μg/0.98 ml | | Injektionslösung im Fertigpen | | H05AA05 | | Palopegteriparatide | | 09.12.2025 | | |
|
| Composition |
| palopegteriparatidum 3387 µg corresp. teriparatidum 294 µg, acidum succinicum, mannitolum, metacresolum, natrii hydroxidum, acidum hydrochloridum q.s. ad pH, aqua ad iniectabile q.s. ad solutionem pro 0.98 ml corresp. natrium 7.475 mg. |
| Packungsbestandteile |
| Injektionslösung im Fertigpen | | | | | | Active Agent | Dose |
|---|
| Palopegteriparatidum | 3387 µg correspond Teriparatide 294 µg |
| | | | Inactive agents |
|---|
| Acidum Hydrochloridum | | Succinic Acid | | Mannitol | | Metacresol | | Sodium Hydroxide |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 2 x 1 | | | B | | No | | 005 | 2 | | | B | | No |
|
